• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较Kollicoat MAE 30 D与用于咖啡因片芯肠溶包衣的商用纤维素衍生物的研究。

Studies comparing Kollicoat MAE 30 D with commercial cellulose derivatives for enteric coating on caffeine cores.

作者信息

Scheiffele S, Kolter K, Schepky G

机构信息

Fachhochschule, Pharmatechnik Dept., Sigmaringen, Germany.

出版信息

Drug Dev Ind Pharm. 1998 Sep;24(9):807-18. doi: 10.3109/03639049809088525.

DOI:10.3109/03639049809088525
PMID:9876531
Abstract

The products that are processed in aqueous form, such as Aqoat MF (suspension), Aquateric (pseudolatex), HP 55 (ammonia-based solution), and Kollicoat MAE 30 D (latex), were compared (in the form of spray dispersions, isolated films prepared from the dispersions, and caffeine-film-coated tablets with 5.5, 8.0, and 11.0 mg film/cm2) with one another and with ethanolic HP 55 S solution. The addition of pigments to all of the liquid preparations, with the exception of the ammoniacal solution of HP 55, led to a slight increase in pH. In each case, the viscosity of both solutions was well above that of the other formulations. The minimum film-forming temperature was decidedly reduced by the addition of pigment. Kollicoat MAE was the undissolved film-former that had the smallest particle size and particle size distribution. The next smallest were those of Aqoat MF. The latex and the suspension were the only products that were sensitive to shear and heat. The isolated films did not display any tack. The strongest films and the films most impermeable to water vapor were obtained from solutions, and this can be ascribed to the fine distribution of the film-former. None of the isolated films showed signs of dissolving at pH 4.5. At pH 5.5, only the HP 55 was dissolved. This was because HP 55 was processed in ammonia-based solution; as a result of which, films that were not very resistant to gastric juice were obtained. The other formulations did not dissolve until the pH reached 6.0. As the pH rose, the rate of dissolution increased for all of the films. The permeability to protons was similar to that of caffeine-film-coated tablets to gastric juice. The resistance increased in the following sequence: HP 55 (ammonia-based) < Aquateric < Aqoat MF < HP 55 S (organic) and Kollicoat MAE. As a result of the temperature treatment and the rate of spraying, the production time on a 5-kg scale was twice as long for 5.5 mg Aqoat MF/cm2 as it was for Kollicoat MAE. This amount of film sufficed for Kollicoat MAE and HP 55 S solution to achieve adequate resistance to gastric juice. Aqoat MF did not attain the same resistance until a thickness of 11 mg film/cm2 was reached. Film tablets with Aquateric and ammonia-based HP 55 solution absorbed more than 20% of gastric juice at this film thickness.

摘要

对以水性形式加工的产品进行了比较,这些产品包括Aqoat MF(悬浮液)、Aquateric(假乳胶)、HP 55(氨溶液)和Kollicoat MAE 30 D(乳胶),比较形式为喷雾分散体、由分散体制备的分离膜以及含5.5、8.0和11.0mg膜/cm²的咖啡因薄膜包衣片,它们之间相互比较,并与乙醇性HP 55 S溶液比较。除HP 55的氨溶液外,向所有液体制剂中添加颜料均导致pH略有升高。在每种情况下,两种溶液的粘度均远高于其他制剂。添加颜料后,最低成膜温度明显降低。Kollicoat MAE是粒径和粒径分布最小的不溶性成膜剂。其次是Aqoat MF的粒径和粒径分布。乳胶和悬浮液是仅对剪切和热敏感的产品。分离膜未表现出任何粘性。从溶液中获得的薄膜强度最高且对水蒸气最具阻隔性,这可归因于成膜剂的精细分布。在pH 4.5时,没有分离膜显示出溶解迹象。在pH 5.5时,只有HP 55溶解。这是因为HP 55是在氨溶液中加工的;因此,获得的薄膜对胃液的耐受性不强。其他制剂直到pH达到6.0才溶解。随着pH升高,所有薄膜的溶解速率均增加。质子渗透性与咖啡因薄膜包衣片对胃液的渗透性相似。耐受性按以下顺序增加:HP 55(氨溶液)<Aquateric<Aqoat MF<HP 55 S(有机溶液)和Kollicoat MAE。由于温度处理和喷雾速率的原因,5kg规模下5.5mg Aqoat MF/cm²的生产时间是Kollicoat MAE的两倍。对于Kollicoat MAE和HP 55 S溶液,该量的薄膜足以获得对胃液的足够耐受性。Aqoat MF直到达到11mg膜/cm²的厚度才获得相同的耐受性。在此薄膜厚度下,含Aquateric和氨溶液型HP 55的薄膜片吸收了超过20%的胃液。

相似文献

1
Studies comparing Kollicoat MAE 30 D with commercial cellulose derivatives for enteric coating on caffeine cores.比较Kollicoat MAE 30 D与用于咖啡因片芯肠溶包衣的商用纤维素衍生物的研究。
Drug Dev Ind Pharm. 1998 Sep;24(9):807-18. doi: 10.3109/03639049809088525.
2
Variation of composition of an enteric formulation based on Kollicoat MAE 30 D.基于Kollicoat MAE 30 D的肠溶制剂的组成变化
Drug Dev Ind Pharm. 2000 Feb;26(2):177-87. doi: 10.1081/ddc-100100342.
3
Comparative studies with Kollicoat MAE 30 D and Kollicoat MAE 30 DP in aqueous spray dispersions and enteric coatings on highly swellable caffeine cores.在高溶胀性咖啡因核心上的水性喷雾分散体和肠溶包衣中,对Kollicoat MAE 30 D和Kollicoat MAE 30 DP进行的比较研究。
Drug Dev Ind Pharm. 2000 Apr;26(4):415-21. doi: 10.1081/ddc-100101248.
4
Evaluation of the drug release patterns and long term stability of aqueous and organic coated pellets by using blends of enteric and gastrointestinal insoluble polymers.通过使用肠溶和胃肠道不溶性聚合物的混合物评估水性和有机包衣微丸的药物释放模式和长期稳定性。
Int J Pharm. 2009 Oct 1;380(1-2):112-9. doi: 10.1016/j.ijpharm.2009.07.013. Epub 2009 Jul 24.
5
Aqueous coating dispersion (pseudolatex) of zein improves formulation of sustained-release tablets containing very water-soluble drug.玉米朊的水性包衣分散体(假胶乳)改善了含有极水溶性药物的缓释片剂的配方。
J Colloid Interface Sci. 2010 May 1;345(1):46-53. doi: 10.1016/j.jcis.2010.01.029. Epub 2010 Jan 18.
6
Physicochemical properties of enteric films prepared from aqueous dispersions and organic solutions.由水分散体和有机溶液制备的肠溶薄膜的物理化学性质。
Int J Pharm. 2006 Apr 26;313(1-2):43-8. doi: 10.1016/j.ijpharm.2006.01.021. Epub 2006 Feb 17.
7
Influence of aqueous coatings on the stability of enteric coated pellets and tablets.水性包衣对肠溶包衣微丸和片剂稳定性的影响。
Eur J Pharm Biopharm. 1999 Jan;47(1):39-50. doi: 10.1016/s0939-6411(98)00086-1.
8
Influence of the components of Kollicoat SR film on mechanical properties of floating pellets from the point of view of tableting.从压片角度看,尤特奇SR薄膜包衣的成分对漂浮微丸机械性能的影响
Pharmazie. 2008 Oct;63(10):731-5.
9
Compression of pellets coated with various aqueous polymer dispersions.用各种水性聚合物分散体包衣的微丸的压制。
Int J Pharm. 2004 Jul 26;279(1-2):19-26. doi: 10.1016/j.ijpharm.2004.03.019.
10
pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat SR 30 D and the enteric polymer dispersion Kollicoat MAE 30 DP.一种碱性药物从包衣有缓释聚合物分散体Kollicoat SR 30 D和肠溶聚合物分散体Kollicoat MAE 30 DP的微丸中实现与pH无关的释放。
Eur J Pharm Biopharm. 2004 Jul;58(1):45-9. doi: 10.1016/j.ejpb.2004.03.013.